[Skip to Content]
Access to paid content on this site is currently suspended due to excessive activity being detected from your IP address 54.163.129.96. Please contact the publisher to request reinstatement.
[Skip to Content Landing]
Article
October 1997

Headache Treatment Trial Methodology and New Drugs

Author Affiliations

Kansas City, Kan

 

edited by J. E. S. Olesen, MD, PhD, and Peter Tfelt-Hansen, PhD, 400 pp, $95, Philadelphia, Pa, Lippincott-Raven Publishers, 1997.

Arch Neurol. 1997;54(10):1199-1200. doi:10.1001/archneur.1997.00550220015005

This article is only available in the PDF format. Download the PDF to view the article, as well as its associated figures and tables.

Abstract

This is a volume of 56 chapters, almost all of them quite brief. The first half of the volume relates to the methodological problems in clinical trials of drugs for the treatment of headache. The second half of the volume contains articles concerning effectiveness of sumatriptan, new methods of its administration, and reports of safety and efficacy of a variety of new 5-hydroxytriptamine 1D agonists in the treatment of migraine. The last section of the book is a potpourri of studies of other agents known to be useful, or considered as possibly useful, in the treatment of migraine—salicylates, substance P agonists, and sodium valproate.

There are several excellent aspects to this volume. The initial chapters enlighten the reader on the basics of clinical drug trials—the phases of research in new drugs and the problems of experimental design, such as decisions regarding the use of crossover vs parallel form studies. Several

First Page Preview View Large
First page PDF preview
First page PDF preview
×